Retatrutide 20mg

Product overview

Batch #: glp3-20-925

Retatrutide is supplied as a lyophilized research peptide for laboratory applications. Product is not sterile and not suitable for human or veterinary use.

Specifications

• Amount per vial: 20 mg

• Lot/Batch: glp3-20-925

• Form / appearance: White lyophilized powder

• Purity (current lot): 99.957% by HPLC with UV detection coupled with mass spectrometry; identity Retatrutide confirmed by mass ID (COA Accession 2509100005, reported 2025-09-11)

• Measured net peptide content: 22.22 mg (laboratory reported)

• Endotoxin (USP <85>, duplicate): ≤0.05 EU/mL – Pass (COA Accession 2509100006)

• Documents: COA(s) downloadable by lot; SDS available on request

• Storage (unopened, dry): −20 °C recommended; protect from light and moisture

  After reconstitution: store 2–8 °C; avoid repeated freeze–thaw; handle per lab SOPs

• Packaging note: Current lot shown with a dark-blue cap on the COA images; cap/label styling may vary by batch. 

Quality & testing

Each lot is independently analyzed via HPLC-UV/MS with mass-spectral confirmation for identity and purity; net content is reported, and endotoxin testing is performed in duplicate per USP <85> with a pass threshold of ≤0.05 EU/mL. See COA pages 1–2 for this lot’s detailed results. 

Handling & shipping

Ships at ambient temperature. Upon receipt, store as directed. Reconstitute with an appropriate research-grade solvent or buffer in accordance with your laboratory’s protocols. Product is not sterile.

Compliance

For laboratory research use only. Not for human or veterinary consumption, diagnostic use, or drug, cosmetic, or household use. No dosing, administration, or health/benefit claims are provided or implied.